stella
beta
Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance — Stella
Recruiting
Back to Ovarian Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
South Korea
Severance Hospital, Seoul
View full record on ClinicalTrials.gov